Product Program year 2024 Source: CMS Open Payments

Jot DX

Device Cardiac Rhythm Management

PDI 05415067040046

Open in the dashboard

General payments

$424,553

13,202 payments

Research payments

$8,725

3 payments

Through program year 2024, $424,553 in general payments and $8,725 in research payments were reported against Jot DX (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $200,650 5,842
2023 General $184,063 6,175
2023 Research $8,725 3
2022 General $39,840 1,185

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $424,553 13,202 payments
Top recipients General payments · program year 2024
  1. Alexander Perino Clinical Cardiac Electrophysiology · Stanford, CA $4,155 2% · 5 payments
  2. James Feldman Cardiovascular Disease · Houston, TX $777 <1% · 8 payments
  3. Alberto Interian Cardiovascular Disease · Miami, FL $711 <1% · 8 payments
  4. Joven Dungo Cardiovascular Disease · Jersey City, NJ $701 <1% · 14 payments
  5. Daniel Musikantow Clinical Cardiac Electrophysiology · New York, NY $668 <1% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Cardiovascular Disease Internal Medicine $56,022 29% · 830 practitioners
  2. Clinical Cardiac Electrophysiology Internal Medicine $45,148 23% · 601 practitioners
  3. Interventional Cardiology Internal Medicine $25,066 13% · 383 practitioners
  4. Physician Assistant $10,033 5% · 159 practitioners
  5. Internal Medicine $9,015 5% · 144 practitioners

The top 5 of 81 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Texas $28,485 14% · 415 recipients
  2. New York $25,567 13% · 345 recipients
  3. California $23,498 12% · 288 recipients
  4. Florida $22,487 11% · 309 recipients
  5. Connecticut $7,263 4% · 75 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

13,202 general · 3 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record